A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19
NCT05164133
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
2
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Tocilizumab
Sponsor
Hoffmann-La Roche